Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alcidion Group Limited ( (AU:ALC) ) has provided an announcement.
Alcidion Group Limited reported a significant turnaround in its financial performance for the fiscal year ending June 2025, achieving a profit of $1.654 million compared to a loss in the previous year. This improvement was driven by a 10% increase in revenue due to new sales in ANZ and the UK, a reduction in staff costs following a restructuring, and an increased income tax benefit. The company also established a new subsidiary in Canada, although it did not contribute to the year’s profit.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing software solutions that enhance clinical workflows and patient care. The company focuses on markets in Australia, New Zealand, and the UK, with recent expansion into Canada.
Average Trading Volume: 1,304,886
Technical Sentiment Signal: Buy
Current Market Cap: A$134.3M
For an in-depth examination of ALC stock, go to TipRanks’ Overview page.